Abnobaviscum Quercus 0.02 mg ampoules (21 pcs)

Area of application

This anthroposophical medicine is used as a supplementary treatment for tumor diseases.According to the anthroposophical knowledge of humanity and nature, it serves to activate the form and integration forces in adults in order to dissolve independent growth processes and reintegrate them into the body.This can be helpful for several types of tumor diseases including:

Malignant tumor diseases, even if they are accompanied by disorders of the blood-forming organs.

Benign tumor diseases.

Prevention of relapses after tumor operations (recurrence prevention).

Precursors of certain cancers (defined precancerous lesions).

Active ingredients / ingredients / ingredients

This preparation contains the following active ingredients and excipients:

0.015 mg oak mistletoe pressed juice.

0.02 mg mistletoe herb.

Viscum album (hom./anthr.).

Ascorbic acid as an excipient.

Disodium hydrogenphosphate 2-water as an auxiliary.

Sodium dihydrogen phosphate 1-water as an excipient.

Water, for injection purposes as an excipient.

Contraindications

The preparation must not be used if you have known allergies to mistletoe preparations.For acute inflammatory or highly febrile illnesses (body temperature above 38°C), treatment should only be started or continued after the fever or inflammation has subsided.It is also not applicable for chronic granulomatous diseases, severe autoimmune diseases under immunosuppressive therapy, and hyperthyroidism with palpitations.

Dosage

The dosage is carried out individually according to the doctor's instructions and depends on the patient's reaction situation.No prescription is required for this product.

Induction phase: Treatment typically begins with a strength of 0.02 mg three times weekly.The dose is then gradually increased until the optimal concentration is reached.The potency levels D 10 - D 30 are used according to individual indications.

Maintenance phase: The individual dose can already be at a strength of 0.02 mg.Otherwise, the concentration is gradually increased to 0.2 mg, 2 mg and 20 mg, each with 2-3 injections per week.If reactions are severe, the dose can be reduced or changed to a lower potency level.The optimal dose should be reviewed at 3-6 month intervals.

Dosage for impaired renal function: There are no specific dosage recommendations for patients with impaired renal function.Experience to date has shown no need for dose adjustment.

Duration of application: The duration of treatment is not limited and is determined by the doctor.It depends on the individual risk of tumor recurrence and the patient's condition.Therapy can last several years, with breaks of increasing length.

Application errors: In the event of an overdose, reactions can occur as described under side effects.The next injection should only be given after these symptoms have subsided and in a reduced dosage.If an application is missed, the normal therapy schedule should be continued.If therapy is discontinued, the low initial dosage must be started again when starting again.

Intake

The subcutaneous injection should, if possible, be carried out near the tumor or metastasis, otherwise in different parts of the body.Do not inject into inflamed skin areas or radiation areas.The injection technique should be learned by an experienced person.Ampoules should be injected immediately after opening and should not be used for subsequent injections.

For potency levels D 10, D 20 and D 30, in special cases the required dose can be mixed into an infusion solution and slowly infused intravenously.The infusion time should last at least 90 minutes for 250 ml.Dosage and frequency are determined individually by the doctor.

Patient information

Particular caution is required when increasing the dose to avoid allergic reactions.After breaks in therapy, the willingness to react may be changed, so that a lower starting dose may be necessary.In the case of primary brain and spinal cord tumors or brain metastases with a risk of increased intracranial pressure, the preparation should only be used if specifically prescribed by a doctor.Before the injection, the ampoule should be briefly warmed in your hand.

It is not known whether the drug affects the ability to drive or use machines. However, if symptoms such as fever occur that are related to the use of the preparation, you should not actively drive or operate machines until these symptoms have subsided.

Pregnancy

There are no data on exposed pregnant women for this preparation.Animal studies do not reveal any particular dangers for humans, but there is a lack of sufficient studies on the effects on birth and postnatal development.Caution is advised when used during pregnancy and breastfeeding and consultation with a doctor is required.

Notes

For information about risks and side effects, read the package leaflet and ask your doctor or pharmacy.

ABNOBAVISCUM Quercus 0.02 mg ampoules.Registered homeopathic medicine, therefore without specifying a therapeutic indication.